New York-Presbyterian/Brooklyn Methodist Hospital is a clinical research site located in Brooklyn, New York, United States 11215.
Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.
New York-Presbyterian/Brooklyn Methodist Hospital has participated in 60 clinical trials with 42 currently active.
Therapeutic areas: Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7.
Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, NRG Oncology.
Trust Score: 85/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
New York-Presbyterian/Brooklyn Methodist Hospital has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
New York-Presbyterian/Brooklyn Methodist Hospital has 60 clinical trials on record, with 42 currently active. Their work covers Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7.
Yes — New York-Presbyterian/Brooklyn Methodist Hospital holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.